Werken bij Siemens HealthineersPersInvestor Relations
  1. Home
  2. Medische beeldvorming
  3. Beeldvorming door magnetische resonantie (MRI)
  4. Opties en upgrades
  5. Klinische softwaretoepassingen
  6. Wave-CAIPI SWI

Wave-CAIPI SWI

WAVE CAIPI SWI

Features & Benefits

Siemens-Healthineers unique Wave-CAIPI SWI exploits coil sensitivity variations in all three dimensions. Together with the optimal CAIPIRINHA voxel aliasing pattern, Wave-CAIPI SWI results in higher acceleration factors, shorter scan times and improved image quality1.

Your benefits:

  • Bringing high-resolution 3D SWI scans from 3-5 minutes to under 2 minutes.2
  • Helpful for cerebral hemorrhage detection.
  • Superior visualization of pathology and overall diagnostic quality compared with T2*w GRE as well as noninferior to standard SWI with reduced scan time and reduced motion artifacts.3
  • Reliable method for the detection and counting of cerebral microbleeds within approximately half of the scan time of conventional SWI.4

General Requirements

System

  • MAGNETOM Altea
  • MAGNETOM Lumina
  • MAGNETOM Sola
  • MAGNETOM Vida
  • MAGNETOM Vida Fit5

Minimum Software Version

syngo MR XA31A

Other

Prerequisite: SWI license

Additional technical prerequisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.

1

Improved image quality can be expected when comparing equivalent acceleration factors for Wave-CAIPI SWI and standard SWI.

2

Data on file.

3

J. Conklin et al.: Validation of Highly Accelerated Wave–CAIPI SWI Compared with Conventional SWI and T2*-Weighted Gradient Recalled-Echo for Routine Clinical Brain MRI at 3T; Am J Neuroradiology https://dx.doi.org/10.3174/ajnr.A6295 (2019)

4

M.S. Chun et al.: Wave-CAIPI susceptibility-weighted imaging achieves diagnostic performance comparable to conventional susceptibility-weighted imaging in half the scan time; Eur Radiol 30:2182-2190 (2020)

5

For MAGNETOM Vida Fit this feature is still under development and not commercially available yet. Its future availability cannot be ensured.